XIAMEN KINGDOMWAY GROUP COMPANY |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.8 CNY | -0.22% |
|
+2.76% | -15.49% |
| Mar. 12 | Xiamen Kingdomway Sets Up US Joint Venture | MT |
| Feb. 13 | Xiamen Kingdomway to Buy US Nutritional Supplements Firm for $17 Million | MT |
| Sales 2021 | 3.62B 499M | Sales 2022 | 3.01B 415M | Capitalization | 12.64B 1.74B |
|---|---|---|---|---|---|
| Net income 2021 | 789M 109M | Net income 2022 | 257M 35.47M | EV / Sales 2021 | 5.38 x |
| Net Debt 2021 | 354M 48.81M | Net Debt 2022 | 293M 40.5M | EV / Sales 2022 | 4.3 x |
| P/E ratio 2021 |
24.3
x | P/E ratio 2022 |
48.2
x | Employees | 2,907 |
| Yield 2021 |
1.92% | Yield 2022 |
0.97% | Free-Float | 40.42% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.22% | ||
| 1 week | +2.76% | ||
| Current month | -11.93% | ||
| 1 month | -0.43% | ||
| 6 months | -19.06% | ||
| Current year | -15.49% |
1 week
13.13
14.14
1 month
12.8016.31
Current year
10.7116.48
1 year
10.7121.17
3 years
10.7151.23
5 years
10.7164.48
10 years
8.1564.48
| Managers | Title | Age | Since |
|---|---|---|---|
Bin Jiang
CEO | Chief Executive Officer | 57 | 96-12-31 |
Hang Hong
DFI | Director of Finance/CFO | 42 | 16-04-11 |
Jia Liang Chen
BRD | Director/Board Member | 60 | 01-05-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Shui Hua Wang
BRD | Director/Board Member | 58 | 15-08-19 |
Bin Jiang
CEO | Chief Executive Officer | 57 | 96-12-31 |
Guo Qing Ma
PRN | Corporate Officer/Principal | 60 | 00-12-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 117 M€ | +0.68% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-25 | 14.06 | +1.88% | 4,991,300 |
| 24-04-24 | 13.8 | -0.22% | 4,522,433 |
| 24-04-23 | 13.83 | +0.22% | 5,330,369 |
| 24-04-22 | 13.8 | +2.30% | 7,106,659 |
| 24-04-19 | 13.49 | +1.12% | 6,720,734 |
End-of-day quote Shenzhen S.E., April 23, 2024
More quotes
Xiamen Kingdomway Group Company is a China-based company principally engaged in the production and distribution of nutrition enhancers and health care products. The Company mainly provides coenzyme Q10 series, including coenzyme Q10 lotion and Q10 powder; vitamin A (VA) series, including food level VA acetate, food level VA palmitate, food level VA palmitate powder, food level VA acetate powder, feed level VA powder and feed level VA acetate oil; health products - capsules series, as well as health products - tablets series, among others. The Company distributes its products within domestic market and to overseas markets.
Sector
Food Processing
Calendar
2024-04-29
- Q1 2024 Earnings Release
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -15.49% | 1.16B | |
| +6.96% | 7.69B | |
| +0.34% | 7.29B | |
| +5.49% | 6.24B | |
| -8.63% | 3.65B | |
| -11.69% | 3.43B | |
| +10.65% | 961M | |
| -42.07% | 918M | |
| -19.29% | 841M | |
| -18.34% | 790M |
- Stock Market
- Equities
- 002626 Stock
